Childhood Diabetes Reduction Act of 2025

**What happened:** On November 25, 2025, Representative Beyer (D-VA-8) introduced HR6294, the Childhood Diabetes Reduction Act of 2025, in the 119th Congress. The bill was referred to the House Committee on Energy and Commerce, where it currently remains with no further action. The bill amends Section 403 of the Federal Food, Drug, and Cosmetic Act to mandate front-of-package warning labels for sugar-sweetened beverages, foods with non-sugar sweeteners, and ultra-processed foods. Labels must occupy at least 5% of the principal display area, contain FDA-specified warning text, and be enclosed in a rectangular border with an exclamation point icon. **The money trail:** HR6294 does not authorize or appropriate any federal spending. It imposes a pure regulatory cost on private industry. The mechanism is a labeling mandate — not a tax, subsidy, or procurement program. The economic impact flows entirely through reduced consumer demand, not government funding. This is a zero-dollar authorization bill with multi-billion-dollar private sector consequences. No taxpayer funds are at stake; no companies receive government contracts or tax credits from this legislation. **Structural winners and losers:** The unambiguous losers are manufacturers of sugar-sweetened beverages and ultra-processed foods. $KO and $PEP face the largest absolute exposure — soda is the primary target, and international precedent from Chile and Mexico demonstrates labeling mandates reduce beverage sales by 8-15%. $MDLZ and $KHC face smaller percentage impacts but significant absolute revenue risk. There are no structural winners from this bill's core provisions. No alternative food or beverage companies benefit directly — artificial sweetener producers may see substitution demand, but the bill equally warns against non-sugar sweeteners, defeating that arbitrage.